CN101757178B - Medicament composition for treating chronic hepatitis and preparation method thereof - Google Patents
Medicament composition for treating chronic hepatitis and preparation method thereof Download PDFInfo
- Publication number
- CN101757178B CN101757178B CN2008103061726A CN200810306172A CN101757178B CN 101757178 B CN101757178 B CN 101757178B CN 2008103061726 A CN2008103061726 A CN 2008103061726A CN 200810306172 A CN200810306172 A CN 200810306172A CN 101757178 B CN101757178 B CN 101757178B
- Authority
- CN
- China
- Prior art keywords
- parts
- chronic hepatitis
- pharmaceutical composition
- preparation
- product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention discloses a medicament composition for treating chronic hepatitis and a preparation method thereof. The medicament composition is prepared from the following materials in parts by weight: 1-5 parts of cassia twig, 1-5 parts of ephedra, 10-30 parts of oldenlandia diffusa, 5-15 parts of tuceahoe, 5-15 parts of angelica sinensis, 5-15 parts of astragalus mongholicus, 5-15 parts of codonopsis pilosula, 5-15 parts of eupolyphaga, 5-15 parts of tortoise shell and 3-7 parts of radix glycyrrhizae preparata. The medicament composition is pure herbal pharmaceutics, has remarkable effect for treating chronic hepatitis, has satisfactory use effect, is convenient to take orally, is safe to use and has no toxic or side effect.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition for the treatment of chronic hepatitis and preparation method thereof, belong to the technical field of Chinese medicine.
Technical background
Hepatitis, especially chronic hepatitis are a kind of diseases of very difficult healing.Chinese medicine thinks that the origin cause of formation of chronic hepatitis is qi stagnation blood stasis, treats with the yin nourishing easing the affected liver, and clearing away heat-damp and promoting diuresis, dispersing the stagnated live-QI to relieve the stagnation of QI, invigorating the spleen and regulating the stomach are main.At present, the Chinese medicine preparation that is used for the treatment of chronic hepatitis on the market is of a great variety, but therapeutic effect is not very desirable, and the toxic and side effects of the Western medicine such as picture interferon is larger, and result of use is bad.
Summary of the invention
The object of the invention is to provide pharmaceutical composition of a kind of evident in efficacy, treatment chronic hepatitis of having no side effect and preparation method thereof.
The invention technical scheme is achieved in that the pharmaceutical composition for the treatment of chronic hepatitis, and this pharmaceutical composition is to be made by the crude drug of following weight parts; 1～5 part of Ramulus Cinnamomi, 1～5 part in Herba Ephedrae, 10～30 parts of Herba Hedyotidis Diffusaes, 5～15 parts in Poria, 5～15 parts of Radix Angelicae Sinensis, 5～15 parts of the Radixs Astragali, 5～15 parts of Radix Codonopsis, 5～15 parts of Eupolyphaga Seu Steleophagas, 5～15 parts of Carapax Et Plastrum Testudiniss, 3～7 parts of Radix Glycyrrhizae Preparatas.
In the pharmaceutical composition of above-mentioned treatment chronic hepatitis, be to be made by the crude drug of following weight preferably; Ramulus Cinnamomi 3g, Herba Ephedrae 3g, Herba Hedyotidis Diffusae 20g, Poria 10g, Radix Angelicae Sinensis 10g, Radix Astragali 10g, Radix Codonopsis 10g, Eupolyphaga Seu Steleophaga 10g, Carapax Et Plastrum Testudinis 10g, Radix Glycyrrhizae Preparata 5g.
The preparation method of the pharmaceutical composition of aforesaid treatment chronic hepatitis, the method are that preparation process is made clinical acceptable peroral dosage form routinely.
The preparation method of the pharmaceutical composition of aforesaid treatment chronic hepatitis, the method are to make oral liquid by following preparation method:
A, add the water that 5-8 doubly measures after crude drug mixed, at 50-60 ℃ of lower lixiviate 1-2 hour, get the A product;
B, the A product were decocted 1-2 hour to get the B product;
C, the B product are filtered after the siphon supernatant, the finished product oral liquid of sterilizing again to get.
Clinical brief summary of the present invention:
1, clinical data: treatment chronic hepatitis 50 examples, the child organizes 2-8 year 26 examples, juvenile group 9-16 year 13 examples, Middle-young age 7 examples, old group 4 examples.In 50 examples, the oldest 60 years old, minimum 5 years old, the course of disease was the longest 5 years, the shortest 2 months.
2, clinical symptoms-show as inappetence, chest distress, sleepy, the thin white fur of tongue of general fatigue, deficient and weak pulse, abdominal distention, limbs are aching and limp etc.
3, Therapeutic Method: every day 1-3 time, each 2-10g, 3-4 week is 1 course for the treatment of.
4, therapeutic effect: in 50 examples, 30 examples of fully recovering, produce effects 13 examples, effective 4 examples, invalid 3 examples (being old group).
5, treatment standard: the complete obiteration of recovery from illness-clinical symptoms, produce effects and effective-clinical symptoms have clear improvement, and invalid-clinical symptoms has no improvement.
6, total effective rate is: 94%.
Compared with the prior art, Drug therapy efficient of the present invention is high, evident in efficacy, and taking convenience, can be directly oral; The present invention is pure Chinese medicinal preparation, and is safe and convenient to use, and has no side effect, and for a long time, finds never that clinically toxicity appears in an example.
The specific embodiment
Embodiment.Get Ramulus Cinnamomi 3g, Herba Ephedrae 3g, Herba Hedyotidis Diffusae 20g, Poria 10g, Radix Angelicae Sinensis 10g, Radix Astragali 10g, Radix Codonopsis 10g, Eupolyphaga Seu Steleophaga 10g, Carapax Et Plastrum Testudinis 10g, Radix Glycyrrhizae Preparata 5g.During preparation, add the water of 8 times of amounts after first the above-mentioned raw materials medicine being mixed, 50-60 ℃ of lower lixiviate 1 hour, get the A product; Then the A product were decocted 1 hour to get the B product; Siphon supernatant after at last the B product being filtered adds correctives, the finished product oral liquid of sterilizing again to get.This product is oral, every day 1-3 time, each 30-50g.
Embodiments of the invention 2: get Ramulus Cinnamomi 5g, Herba Ephedrae 5g, Herba Hedyotidis Diffusae 30g, Poria 15g, Radix Angelicae Sinensis 15g, Radix Astragali 15g, Radix Codonopsis 15g, Eupolyphaga Seu Steleophaga 15g, Carapax Et Plastrum Testudinis 15g, Radix Glycyrrhizae Preparata 7g, formulation method is made tablet routinely, every day 1-3 time, each 1-3 sheet.Also formulation method is made the peroral dosage forms such as capsule, soft capsule, granule and pill routinely.
Claims (4)
1. treat the pharmaceutical composition of chronic hepatitis, it is characterized in that: this pharmaceutical composition is to be made by the crude drug of following weight parts; 1～5 part of Ramulus Cinnamomi, 1～5 part in Herba Ephedrae, 10～30 parts of Herba Hedyotidis Diffusaes, 5～15 parts in Poria, 5～15 parts of Radix Angelicae Sinensis, 5～15 parts of the Radixs Astragali, 5～15 parts of Radix Codonopsis, 5～15 parts of Eupolyphaga Seu Steleophagas, 5～15 parts of Carapax Et Plastrum Testudiniss, 3～7 parts of Radix Glycyrrhizae Preparatas.
2. the pharmaceutical composition for the treatment of chronic hepatitis according to claim 1, it is characterized in that: this pharmaceutical composition is to be made by the crude drug of following weight; Ramulus Cinnamomi 3g, Herba Ephedrae 3g, Herba Hedyotidis Diffusae 20g, Poria 10g, Radix Angelicae Sinensis 10g, Radix Astragali 10g, Radix Codonopsis 10g, Eupolyphaga Seu Steleophaga 10g, Carapax Et Plastrum Testudinis 10g, Radix Glycyrrhizae Preparata 5g.
3. the preparation method of the pharmaceutical composition for the treatment of chronic hepatitis according to claim 1 and 2, it is characterized in that: the method is that preparation process is made clinical acceptable peroral dosage form routinely.
4. the preparation method of the pharmaceutical composition for the treatment of chronic hepatitis according to claim 3, it is characterized in that: the method is to make oral liquid by following preparation method:
A, add the water that 5-8 doubly measures after crude drug mixed, at 50-60 ℃ of lower lixiviate 1-2 hour, get the A product;
B, the A product were decocted 1-2 hour to get the B product;
C, the B product are filtered after the siphon supernatant, the finished product oral liquid of sterilizing again to get.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008103061726A CN101757178B (en) | 2008-12-11 | 2008-12-11 | Medicament composition for treating chronic hepatitis and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2008103061726A CN101757178B (en) | 2008-12-11 | 2008-12-11 | Medicament composition for treating chronic hepatitis and preparation method thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101757178A CN101757178A (en) | 2010-06-30 |
| CN101757178B true CN101757178B (en) | 2013-04-24 |
Family
ID=42488660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2008103061726A Expired - Fee Related CN101757178B (en) | 2008-12-11 | 2008-12-11 | Medicament composition for treating chronic hepatitis and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101757178B (en) |
-
2008
- 2008-12-11 CN CN2008103061726A patent/CN101757178B/en not_active Expired - Fee Related
Non-Patent Citations (2)
| Title |
|---|
| 余孝奎.乙型肝炎辨治八法.《中医研究》.2008,第21卷(第09期),54-56. * |
| 王光辉等.常见肝胆病证的中医诊断及治疗.《社区医学杂志》.2006,第04卷(第09期),4-8. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101757178A (en) | 2010-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101130030B (en) | Medicine composition for treating nephropathy and uses of the same | |
| CN103566236B (en) | A kind for the treatment of of arthritis and promoting collateral and channels Chinese medicine preparation | |
| CN103386074B (en) | Traditional Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
| CN104971215A (en) | Traditional Chinese medicine composition for treating spleen-deficiency gastrasthenia type chronic gastritis and preparation method thereof | |
| CN102698180A (en) | Chinese medicine for radically treating stomach diseases | |
| CN101380442B (en) | Agent for treating tummy bug and duodenum ulcer | |
| CN101912577B (en) | Medicament for treating rheumatism and rheumatoid disease and preparation process | |
| CN103784918A (en) | Medicine composition for treating regurgitation-induced quidding of equus animals | |
| CN102988942A (en) | Chinese medicament for treating child anorexia | |
| CN103656013A (en) | Traditional Chinese medicine for treating gastrointestinal hypofunction after abdominal operations and preparation method of traditional Chinese medicine | |
| CN101757178B (en) | Medicament composition for treating chronic hepatitis and preparation method thereof | |
| CN103656453A (en) | Semen litchi stomach-nourishing condensed pill and preparation method thereof | |
| CN100438895C (en) | Medicine for treating stomachache and method for preparing same | |
| CN101745093B (en) | Medicine for quickly treating infantile chronic diarrhea | |
| CN104587131A (en) | Traditional Chinese medicinal composition for treating delayed menorrhea | |
| CN104147229B (en) | A kind of compound Chinese medicinal preparation for the treatment of female climacteric syndrome kidney yin and yang deficiency type | |
| CN103494939A (en) | Traditional Chinese medicine for treating senile habitual constipation | |
| CN102727755A (en) | Traditional Chinese medicine composition for treating gastric ulcer | |
| CN102205087B (en) | Chinese medicinal composition for treating chronic gastritis and preparation method thereof | |
| CN102274358B (en) | Traditional Chinese medicine for treating premature menstruation, profuse menstruation, breast distending pain and large clot quantity | |
| CN102836407B (en) | Medicament for treating chronic colitis | |
| CN109700995B (en) | A pharmaceutical composition for treating peptic ulcer, and its preparation method | |
| CN102379913B (en) | Pharmaceutical composition for treating subinvolution of uterus, and preparation method and use thereof | |
| CN101352496A (en) | Chinese medicine for treating hepatitis | |
| CN104758542A (en) | Traditional Chinese medicine composition for treating uterine prolapse caused by deficiency of kidney qi |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130424 Termination date: 20131211 |